Media Lab SpAXPAR:MLLAB 74 EBITDA Margin % is 22.77% as of Dec. 2025, which is 37% above its 10-year median of 16.58. GuruFocus rates XPAR:MLLAB with a GF Score™ of 74/100 and a GF Value™ of €1.74 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Media Lab SpA ranks better than 80.93% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Media Lab SpA's EBITDA for the
six
months ended in Dec. 2025 was €0.32 Mil. Media Lab SpA's Revenue for the
six
months ended in Dec. 2025 was €1.40 Mil. Therefore, Media Lab SpA's EBITDA margin for the quarter that ended in Dec. 2025 was 22.77%.
Media Lab SpA (XPAR:MLLAB) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Media Lab SpA EBITDA Margin % Related Terms
Media Lab SpA EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Media Lab SpA's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:MLLAB vs VEEV, BTSG, TEM: EBITDA Margin % Comparison
For the Health Information Services subindustry, Media Lab SpA's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Media Lab SpA EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Media Lab SpA's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Media Lab SpA's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Media Lab SpA (XPAR:MLLAB) has a EBITDA Margin % of 22.77% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Media Lab SpA and its competitors. This is 37% above median its historical median of 16.58. Over the past decade, Media Lab SpA's EBITDA Margin % has ranged from 7.89 to 31.15. According to the industry distribution chart, Media Lab SpA ranks #127 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 19.1%.
Is Media Lab SpA's EBITDA Margin % too high?
Media Lab SpA's current EBITDA Margin % of 22.77% is 37% above median its 10-year median of 16.58. Over the past 10 years, this metric has ranged from a low of 7.89 to a high of 31.15. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Media Lab SpA's value of 22.77% is 123% above this industry median. Based on the distribution chart, Media Lab SpA ranks #127 out of 666 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Media Lab SpA has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Media Lab SpA's EBITDA Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Media Lab SpA ranks #127 out of 666 companies for EBITDA Margin %. This places Media Lab SpA in the top 19% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. Media Lab SpA's value of 22.77% is 123% above this benchmark. Historically, Media Lab SpA's own EBITDA Margin % has ranged from 7.89 to 31.15 over the past decade. While the company's 10-year median is 16.58 vs. the industry median of 10.21, Media Lab SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Media Lab SpA's current EBITDA Margin % of 22.77% is 123% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Media Lab SpA and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Media Lab SpA's current EBITDA Margin % is 22.77%, which is 37% above median its own 10-year median of 16.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Media Lab SpA stock overvalued right now?
Based on GuruFocus' analysis, Media Lab SpA (XPAR:MLLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.74, compared to a current price of €3.20 — trading 83.9% above its estimated fair value. The current EBITDA Margin % is 22.77%, which is 37% above median its 10-year median of 16.58 and 123% above the Healthcare Providers & Services industry median of 10.21. Media Lab SpA's overall GF Score™ is 74/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Media Lab SpA (XPAR:MLLAB), the current EBITDA Margin % is 22.77% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Media Lab SpA (XPAR:MLLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Media Lab SpA stock appears to be overvalued.
The current stock price of €3.20 is trading 83.9% above its estimated GF Value™ of €1.74.
GuruFocus considers Media Lab SpA to be Significantly Overvalued.
Key valuation signals for XPAR:MLLAB:
EBITDA Margin %: 22.77% (37% above median its 10-year median of 16.58)
GF Value™: €1.74 vs. price of €3.20 (83.9% above fair value)
Industry Position: 123% above the Healthcare Providers & Services median (#127 of 666)
No single metric tells the full story. See the XPAR:MLLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Media Lab SpA provides IT services for the dental sector. It is engaged in the development of software dedicated to the dental market. The company's products include Implant 3D, Guidedesign, Confident among others.
74GF Score
Get the complete analysis for XPAR:MLLAB
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLLAB has been successfully added to your 
